Circulating inflammatory proteins associate with response to immune checkpoint inhibition therapy in patients with advanced melanoma.
- DOI
- 10.1016/j.ebiom.2022.104235
- Published
- 2022 Sep
- Container
- EBioMedicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ebiom.2022.104235,
title = {Circulating inflammatory proteins associate with response to immune checkpoint inhibition therapy in patients with advanced melanoma.},
author = {Rossi N and Lee KA and Bermudez MV and Visconti A and Thomas AM and Bolte LA and Björk JR and de Ruijter LK and Newton-Bishop J and Harland M and Shaw HM and Harries M and Sacco J and Board R and Lorigan P and de Vries EGE and Segata N and Taams L and Papa S and Spector TD and Nathan P and Weersma RK and Hospers GAP and Fehrmann RSN and Bataille V and Falchi M},
year = {2022},
journal = {EBioMedicine},
doi = {10.1016/j.ebiom.2022.104235},
url = {https://doi.org/10.1016/j.ebiom.2022.104235}
}RIS
TY - JOUR TI - Circulating inflammatory proteins associate with response to immune checkpoint inhibition therapy in patients with advanced melanoma. AU - Rossi N AU - Lee KA AU - Bermudez MV AU - Visconti A AU - Thomas AM AU - Bolte LA AU - Björk JR AU - de Ruijter LK AU - Newton-Bishop J AU - Harland M AU - Shaw HM AU - Harries M AU - Sacco J AU - Board R AU - Lorigan P AU - de Vries EGE AU - Segata N AU - Taams L AU - Papa S AU - Spector TD AU - Nathan P AU - Weersma RK AU - Hospers GAP AU - Fehrmann RSN AU - Bataille V AU - Falchi M PY - 2022 JO - EBioMedicine DO - 10.1016/j.ebiom.2022.104235 UR - https://doi.org/10.1016/j.ebiom.2022.104235 ER -
APA
N, R., KA, L., MV, B., A, V., AM, T., LA, B., JR, B., LK, D. R., J, N., M, H., HM, S., M, H., J, S., R, B., P, L., EGE, D. V., N, S., L, T., S, P., TD, S., P, N., RK, W., GAP, H., RSN, F., V, B., & M, F. (2022). Circulating inflammatory proteins associate with response to immune checkpoint inhibition therapy in patients with advanced melanoma.. EBioMedicine. https://doi.org/10.1016/j.ebiom.2022.104235
Source records
- pubmed · retrieved 2026-09-25T12:47:25.223Z